Diedrich Daniel A, Wedel Denise J
Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
J Clin Anesth. 2006 Jun;18(4):286-92. doi: 10.1016/j.jclinane.2005.08.016.
Thyrotoxic periodic paralysis (TPP) is a disease characterized by recurrent episodes of paralysis and hypokalemia during a thyrotoxic state. The disease primarily affects people of Asian descent, but can affect other ethnic groups. In Asians, the symptoms of thyrotoxicosis are distinct and usually precede the first paralytic episode, whereas in non-Asian populations, paralysis is the presenting symptom. If TPP has not been diagnosed and the patient has a surgical procedure during general or regional anesthesia, symptoms of the disease may be confused with other adverse perioperative events such as delayed recovery from neuromuscular paralysis. No specific anesthetic regimen is superior. Current TTP treatment recommendations involve treating the underlying hyperthyroid state. Other modalities such as beta-blockade and potassium replacement are also important in the acute paralytic state. Future diagnostic and treatment innovations may lie in the genetic and molecular understanding of this disease. We present a case of an Asian male with known TPP undergoing general anesthesia, a brief case series involving 5 patients, and a review of the literature.
甲状腺毒症性周期性瘫痪(TPP)是一种在甲状腺毒症状态下以反复出现瘫痪和低钾血症为特征的疾病。该疾病主要影响亚洲血统的人,但也可影响其他种族群体。在亚洲人中,甲状腺毒症的症状较为明显,通常先于首次瘫痪发作出现,而在非亚洲人群中,瘫痪是首发症状。如果TPP未被诊断出来,且患者在全身麻醉或区域麻醉期间接受手术,该疾病的症状可能会与其他围手术期不良事件混淆,如神经肌肉麻痹恢复延迟。没有哪种特定的麻醉方案更具优势。目前TPP的治疗建议包括治疗潜在的甲状腺功能亢进状态。在急性瘫痪状态下,其他治疗方式如β受体阻滞剂和补钾也很重要。未来的诊断和治疗创新可能在于对该疾病的基因和分子层面的理解。我们报告一例已知患有TPP的亚洲男性接受全身麻醉的病例、一个包含5例患者的简短病例系列以及对相关文献的综述。